Literature DB >> 31732820

Cardiac MRI Evaluation of Myocarditis.

Lewis Hahn1, Seth Kligerman2.   

Abstract

PURPOSE OF REVIEW: Cardiac MRI (CMR) is the non-invasive test of choice for the assessment of myocarditis. In 2009, the Lake Louise Criteria for the diagnosis of myocarditis using CMR were first released. The decade since that time has vastly improved our understanding of CMR's strengths and limitations. Traditional CMR methods including T2-weighted imaging and late gadolinium enhancement have proven their diagnostic value, but diagnostic performance is dependent on patient presentation. RECENT
FINDINGS: Newer parametric mapping techniques have begun to be more comprehensively studied and may improve diagnostic accuracy of CMR in an expanded set of clinical scenarios. Additionally, the prognostic value of CMR has begun to solidify. These advances culminated in an update to the Lake Louise Criteria at the end of 2018. In this review, we discuss the evolution of the diagnostic criteria for CMR in the assessment of myocarditis. We also discuss the pathophysiologic premises behind the use of specific MRI sequences and an up-to-date summary of their individual utility.

Entities:  

Keywords:  Acute myocarditis; Cardiac MRI; Chronic myocarditis

Year:  2019        PMID: 31732820     DOI: 10.1007/s11936-019-0757-9

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  63 in total

1.  CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis.

Authors:  Marco Francone; Cristina Chimenti; Nicola Galea; Fernanda Scopelliti; Romina Verardo; Roberto Galea; Iacopo Carbone; Carlo Catalano; Francesco Fedele; Andrea Frustaci
Journal:  JACC Cardiovasc Imaging       Date:  2014-02-19

2.  Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis.

Authors:  Shagun Sachdeva; Xiaoyan Song; Niti Dham; Deneen M Heath; Roberta L DeBiasi
Journal:  Am J Cardiol       Date:  2014-11-29       Impact factor: 2.778

3.  Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.

Authors:  Syed S Mahmood; Michael G Fradley; Justine V Cohen; Anju Nohria; Kerry L Reynolds; Lucie M Heinzerling; Ryan J Sullivan; Rongras Damrongwatanasuk; Carol L Chen; Dipti Gupta; Michael C Kirchberger; Magid Awadalla; Malek Z O Hassan; Javid J Moslehi; Sachin P Shah; Sarju Ganatra; Paaladinesh Thavendiranathan; Donald P Lawrence; John D Groarke; Tomas G Neilan
Journal:  J Am Coll Cardiol       Date:  2018-03-19       Impact factor: 24.094

4.  Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis.

Authors:  Anja Zagrosek; Hassan Abdel-Aty; Philipp Boyé; Ralf Wassmuth; Daniel Messroghli; Wolfgang Utz; Andre Rudolph; Steffen Bohl; Rainer Dietz; Jeanette Schulz-Menger
Journal:  JACC Cardiovasc Imaging       Date:  2009-02

Review 5.  Advances in parametric mapping with CMR imaging.

Authors:  Michael Salerno; Christopher M Kramer
Journal:  JACC Cardiovasc Imaging       Date:  2013-07

6.  Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).

Authors:  Daniel R Messroghli; James C Moon; Vanessa M Ferreira; Lars Grosse-Wortmann; Taigang He; Peter Kellman; Julia Mascherbauer; Reza Nezafat; Michael Salerno; Erik B Schelbert; Andrew J Taylor; Richard Thompson; Martin Ugander; Ruud B van Heeswijk; Matthias G Friedrich
Journal:  J Cardiovasc Magn Reson       Date:  2017-10-09       Impact factor: 5.364

Review 7.  Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases.

Authors:  Jakub Lagan; Matthias Schmitt; Christopher A Miller
Journal:  Int J Cardiovasc Imaging       Date:  2017-01-27       Impact factor: 2.357

8.  Myocarditis with checkpoint inhibitor immunotherapy: case report of late gadolinium enhancement on cardiac magnetic resonance with pathology correlate.

Authors:  Cesia Gallegos; Douglas Rottmann; Vinh Q Nguyen; Lauren A Baldassarre
Journal:  Eur Heart J Case Rep       Date:  2019-01-07

9.  Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR.

Authors:  Rocio Hinojar; Lucy Foote; Eduardo Arroyo Ucar; Thomas Jackson; Andrew Jabbour; Chung-Yao Yu; Jane McCrohon; David M Higgins; Gerry Carr-White; Manuel Mayr; Eike Nagel; Valentina O Puntmann
Journal:  JACC Cardiovasc Imaging       Date:  2014-12-10

10.  Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis.

Authors:  Colin G Stirrat; Shirjel R Alam; Thomas J MacGillivray; Calum D Gray; Marc R Dweck; Kevin Dibb; Nick Spath; John R Payne; Sanjay K Prasad; Roy S Gardner; Saeed Mirsadraee; Peter A Henriksen; Scott Ik Semple; David E Newby
Journal:  Heart       Date:  2017-10-06       Impact factor: 7.365

View more
  3 in total

1.  Persistent Cardiac Magnetic Resonance Imaging Features of Myocarditis Detected Months After COVID-19 Infection.

Authors:  Basel Abdelazeem; Mariem Borcheni; Saed Alnaimat; Sagar Mallikethi-Reddy; Abdulbaset Sulaiman
Journal:  Cureus       Date:  2021-04-01

2.  Symptomatic Young Adults with ST-Segment Elevation-Acute Coronary Syndrome or Myocarditis: The Three-Factor Diagnostic Model.

Authors:  Paulina Wieczorkiewicz; Katarzyna Przybylak; Karolina Supel; Michal Kidawa; Marzenna Zielinska
Journal:  J Clin Med       Date:  2022-02-10       Impact factor: 4.241

3.  Altered Phenotype of Circulating Dendritic Cells and Regulatory T Cells from Patients with Acute Myocarditis.

Authors:  Paola Del Carmen Guerra-de-Blas; Daniela Cruz-González; Elena B Martínez-Shio; Roberto González-Amaro; Héctor González-Pacheco; Esther Layseca-Espinosa; Carlos D Escobedo-Uribe; Adriana E Monsiváis-Urenda
Journal:  J Immunol Res       Date:  2022-02-28       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.